Neurophysiopathological aspects of paclitaxel-induced peripheral neuropathy

R Velasco-González, U Coffeen - Neurotoxicity research, 2022 - Springer
Chemotherapy is widely used as a primary treatment or adjuvant therapy for cancer. Anti-
microtubule agents (such as paclitaxel and docetaxel) are used for treating many types of …

[HTML][HTML] Tapering opioids: a comprehensive qualitative review

MP Davis, G Digwood, Z Mehta… - Annals of palliative …, 2020 - apm.amegroups.org
This state-of-the-art review comprehensive covers the benefits and risks of tapering opioids.
The review discusses opioid strategies and pitfalls that may occur during tapering. The …

[HTML][HTML] Long-term safety and efficacy of angioplasty of femoropopliteal artery disease with drug-coated balloons from the AcoArt I trial

Y Xu, J Liu, J Zhang, B Zhuang, X Jia, W Fu… - Journal of Vascular …, 2021 - Elsevier
Objective We evaluated the long-term safety and efficacy of treatment using drug-coated
balloons (DCBs) in Chinese patients with severe femoropopliteal artery (FPA) disease …

[HTML][HTML] Mechanisms underlying gastrodin alleviating vincristine-induced peripheral neuropathic pain

X Wang, B Zhang, X Li, X Liu, S Wang, Y Xie… - Frontiers in …, 2021 - frontiersin.org
Gastrodin (GAS) is the main bioactive ingredient of Gastrodia, a famous Chinese herbal
medicine widely used as an analgesic, but the underlying analgesic mechanism is still …

Assessment of neuropathic pain following cancer treatment

NA Moloney, D Lenoir - The Anatomical Record, 2024 - Wiley Online Library
Neuropathic cancer pain (NCP) is prevalent affecting up to 58% of those with persistent pain
following cancer treatment. Neuropathic pain can develop from malignancy, after neural …

[HTML][HTML] Presence and distress of chemotherapy-induced peripheral neuropathy symptoms in upper extremities of younger and older breast cancer survivors

S Storey, A Cohee, D Von Ah, E Vachon… - Journal of Patient …, 2020 - ncbi.nlm.nih.gov
Purpose The purposes of this study were to determine whether the presence of upper
extremity chemotherapy-induced peripheral neuropathy (CIPN) symptoms (burning …

Oral pharmacotherapeutics for the management of peripheral neuropathic pain conditions–a review of clinical trials

NN Knezevic, F Jovanovic, KD Candido… - Expert Opinion on …, 2020 - Taylor & Francis
Introduction Epidemiological studies have shown that 6.9–10% of people suffer from
neuropathic pain, a complex painful condition which is often undertreated. Data regarding …

Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study

AA Argyriou, J Bruna, F Kalofonou… - Journal of the …, 2024 - Wiley Online Library
Objective To define the incidence and risk factors for developing chemotherapy‐induced
neuropathic pain (CINP). Methods Retrospective, file‐based analysis on cancer patients …

How common are chronic residual limb pain, phantom pain, and back pain more than 20 years after lower limb amputation for malignant tumors?

K Döring, C Trost, C Hofer, M Salzer… - Clinical Orthopaedics …, 2021 - journals.lww.com
Background After major lower limb amputation, persistent pain is common, with up to 85% of
patients reporting recurring phantom or residual-limb pain. Although pain management is an …

Agrili Kemik Metastazlarinda Onkolojik Yaklasimlar/Oncologic Approaches for Bone Metastasis Related Pain.

E Yekedüz, G Utkan, Y Ürün - Nuclear Medicine Seminars, 2020 - go.gale.com
Ileri evre kanser hastalarinda kemikler akciger ve karacigerden sonra üçüncü en sik
metastaz görülen bölgedir. Kemik metastazlarina bagli agri, tümöral dokunun lokal basi …